These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 6375550

  • 21. Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans.
    An M, Shen H, Cao Y, Zhang J, Cai Y, Wang R, Jiang Y.
    Int J Antimicrob Agents; 2009 Mar; 33(3):258-63. PubMed ID: 19095412
    [Abstract] [Full Text] [Related]

  • 22. [Sterol affinity of Candida albicans cells resistant to polyene antibiotics].
    Virina AM, Belousova II, Tereshin IM.
    Antibiotiki; 1979 Oct; 24(10):755-8. PubMed ID: 386937
    [Abstract] [Full Text] [Related]

  • 23. Antifungal effect of various essential oils against Candida albicans. Potentiation of antifungal action of amphotericin B by essential oil from Thymus vulgaris.
    Giordani R, Regli P, Kaloustian J, Mikaïl C, Abou L, Portugal H.
    Phytother Res; 2004 Dec; 18(12):990-5. PubMed ID: 15742351
    [Abstract] [Full Text] [Related]

  • 24. Exposure of the yeast Candida albicans to the anti-neoplastic agent adriamycin increases the tolerance to amphotericin B.
    O'Keeffe J, Doyle S, Kavanagh K.
    J Pharm Pharmacol; 2003 Dec; 55(12):1629-33. PubMed ID: 14738588
    [Abstract] [Full Text] [Related]

  • 25. [The effect of ultrasonic oscillations and amphotericin B on the ultrastructure of yeast-like fungi in the genus Candida].
    Romanenko IM.
    Vestn Dermatol Venerol; 1990 Dec; (12):27-9. PubMed ID: 2094097
    [Abstract] [Full Text] [Related]

  • 26. Arachidonic acid increases antifungal susceptibility of Candida albicans and Candida dubliniensis.
    Ells R, Kock JL, Van Wyk PW, Botes PJ, Pohl CH.
    J Antimicrob Chemother; 2009 Jan; 63(1):124-8. PubMed ID: 18971215
    [Abstract] [Full Text] [Related]

  • 27. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells.
    Hawser S.
    J Med Vet Mycol; 1996 Jan; 34(2):149-52. PubMed ID: 8732362
    [Abstract] [Full Text] [Related]

  • 28. Amphotericin B susceptibility of Candida species assessed by rapid flow cytometric membrane potential assay.
    Ordóñez JV, Wehman NM.
    Cytometry; 1995 Jun 15; 22(2):154-7. PubMed ID: 7587748
    [Abstract] [Full Text] [Related]

  • 29. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
    Melkusová S, Bujdáková H, Volleková A, Myoken Y, Mikami Y.
    Pharmazie; 2004 Jul 15; 59(7):573-4. PubMed ID: 15296100
    [Abstract] [Full Text] [Related]

  • 30. Effect of a polyene antibiotic on growth and phosphate uptake by Candida albicans.
    Berdicevsky I, Grossowicz N.
    J Gen Microbiol; 1977 Oct 15; 102(2):299-304. PubMed ID: 336844
    [Abstract] [Full Text] [Related]

  • 31. A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans.
    Manavathu EK, Ramesh MS, Baskaran I, Ganesan LT, Chandrasekar PH.
    J Antimicrob Chemother; 2004 Feb 15; 53(2):386-9. PubMed ID: 14729762
    [Abstract] [Full Text] [Related]

  • 32. Antifungal activity of four tetracycline analogues against Candida albicans in vitro: potentiation by amphotericin B.
    Lew MA, Beckett KM, Levin MJ.
    J Infect Dis; 1977 Aug 15; 136(2):263-70. PubMed ID: 408426
    [Abstract] [Full Text] [Related]

  • 33. Lysozyme-enhanced killing of Candida albicans and Coccidioides immitis by amphoteracin B.
    Collins MS, Pappagianis D.
    Sabouraudia; 1974 Nov 15; 12(3):329-40. PubMed ID: 4610825
    [No Abstract] [Full Text] [Related]

  • 34. Serotonin (5-HT) enhances the activity of amphotericin B against Aspergillus fumigatus in vitro.
    Heller I, Leitner S, Dierich MP, Lass-Flörl C.
    Int J Antimicrob Agents; 2004 Oct 15; 24(4):401-4. PubMed ID: 15380269
    [Abstract] [Full Text] [Related]

  • 35. Antioxidant-mediated increases in the antifungal activities of amphotericin B and its methyl ester derivative.
    Beggs WH, Andrews FA.
    Res Commun Chem Pathol Pharmacol; 1980 Aug 15; 29(2):389-92. PubMed ID: 6997948
    [Abstract] [Full Text] [Related]

  • 36. Characteristics of amphotericin B-induced endothelial cell injury.
    Cutaia M, Bullard SR, Rudio K, Rounds S.
    J Lab Clin Med; 1993 Feb 15; 121(2):244-56. PubMed ID: 8381844
    [Abstract] [Full Text] [Related]

  • 37. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y, Akşit F, Kiraz N, Kiremitçi A.
    Mikrobiyol Bul; 2008 Jan 15; 42(1):149-55. PubMed ID: 18444574
    [Abstract] [Full Text] [Related]

  • 38. Adriamycin alters the expression of drug efflux pumps and confers amphotericin B tolerance in Candida albicans.
    O'Keeffe J, Kavanagh K.
    Anticancer Res; 2004 Jan 15; 24(2A):405-8. PubMed ID: 15152937
    [Abstract] [Full Text] [Related]

  • 39. Lipid-covered drug particles: combined action of dioctadecyldimethylammonium bromide and amphotericin B or miconazole.
    Lincopan N, Carmona-Ribeiro AM.
    J Antimicrob Chemother; 2006 Jul 15; 58(1):66-75. PubMed ID: 16636081
    [Abstract] [Full Text] [Related]

  • 40. Enhancement of the fungicidal activity of amphotericin B by allicin, an allyl-sulfur compound from garlic, against the yeast Saccharomyces cerevisiae as a model system.
    Ogita A, Fujita K, Taniguchi M, Tanaka T.
    Planta Med; 2006 Oct 15; 72(13):1247-50. PubMed ID: 16902870
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.